Leukoreduction in the setting of open heart surgery: A prospective cohort-controlled study

Transfusion

Volumn 44, Issue 1, 2004, Pages 30-35

  Fung, Mark K ^b   Rao, Nalini ^b   Rice, Janet ^b   Ridenour, Marilyn ^b   Mook, William ^b   Triulzi, Darrell J ^a  

^a INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOIMMUNIZATION; ARTICLE; BLOOD; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; IMMUNOMODULATION; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; OPEN HEART SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SURGICAL MORTALITY;

AGED; CARDIAC SURGICAL PROCEDURES; CELL SEPARATION; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LEUKOCYTES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0842324891     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2003.00601.x     Document Type: Article

References (18)

1. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
2. Leukocyte reduction and ultraviolet B, irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-9.
3. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusion. Transfusion 1993;33:794-7.
4. Heddle NM, Klama L, Meyer R, et al. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999;39:231-8.
5. Heddle NM, Blajchman MA, Meyer RM, et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002;42:556-66.
6. Van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998;97:562-8.
7. Dzik WH, Anderson JK, O'Neill EM, et al. A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002;42:1114-22.
8. Wallis JP, Chapman CE, Orr KE, et al. Effect of WBC reduction of RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002;42:1127-34.
9. Volkova N, Klapper E, Pepkowitz SH, et al. A case-control study of the impact of WBC reduction on the cost of hospital care for patients undergoing coronary artery bypass graft surgery. Transfusion 2002;42:1123-6.
10. Blumberg N, Heal JM, Cowles J, et al. Leukoreduced transfusions in cardiac surgery: results of an implementation trial. Am J Clin Pathol 2002;118:376-81.
11. Bracey AW, Radovancevic R, Nussmeier NA. Leukocyte-reduced blood in open heart surgery patients: effects on outcome. Transfusion 2002;42(Suppl):5S.
12. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
13. Jensen LS, Kissmeyer-Nielsen P, Wolff B, et al. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-5.
14. Tartter PI, Mohandas K, Azar P, et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;176:462-6.
15. Ortolano GA, Aldea GS, Lilly K, et al. A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects. Perfusion 2002;17:53-62.
16. Asimakopoulos G. The inflammatory response to CPB. the role of leukocyte filtration. Perfusion 2002;17(Suppl): 7-10.
17. Variables involved in STS risk modeling (Internet). Chicaco: The Society of Thoracic Surgeons; c2003 (accessed 2003 May 20). Available from: http://www.sts.org/file/VariableList.pdf
18. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-17.